MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-MH-21-0021173
Primeval Pharma Private Limited
Primeval Pharma Private Limited - chemicals in Nanded, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2024
₹73,864
▼ 4% YoY
Net loss · FY 2024
₹6,432
Net margin -8.7%
EBITDA · FY 2024
-₹6,432
EBITDA margin -8.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Primeval Pharma Private Limited
Data last updated:
Primeval Pharma Private Limited is a private limited company based in Nanded, Maharashtra, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 08 March 2022.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24299MH2022PTC378118.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shrikant Madhavrao Kshirsagar and Rangnath Dnyaneshwar Gaikwad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.16 New Mondha Market Nanded Waghala (M Corp), Maharashtra, India – 431603.
As per the financials filed for FY 2024, the company reported a revenue of ₹73,864, a decline of 4% compared to the previous year. For the same year it recorded a net loss of ₹6,432 (net margin -8.7%) and EBITDA of -₹6,432 (EBITDA margin -8.7%).
Primeval Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-21-0021173).
Company details
CIN U24299MH2022PTC378118
Registration Number 378118
Incorporation Date 08 March 2022
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-21-0021173
Recognitions & Rankings of Primeval Pharma
Contact details
Primeval Pharma Private Limited's registered office is in Nanded, Maharashtra.
- Registered AddressPlot No.16 New Mondha Market Nanded Waghala (M Corp), Maharashtra, India – 431603
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Primeval Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Primeval Pharma Private Limited
FY 2025 filings availablePrimeval Pharma Private Limited reported revenue of ₹73,864 (down 4% YoY) for FY 2024.
Revenue · FY 2024
₹73,864 ▼ 4%
Net loss · FY 2024
₹6,432 margin -8.7%
EBITDA · FY 2024
-₹6,432 margin -8.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 4%
EBITDA CAGR growth
1 year
▼ 671%
Revenue fell 4% in the latest year. EBITDA fell 671% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹6,432 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹6,432 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -8.7% | ||
| Net Profit Margin | -8.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Primeval Pharma Private Limited, buy the company report.
Board of directors of Primeval Pharma Private Limited
Primeval Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shrikant Madhavrao Kshirsagar | Director | 19 Apr 2024 | 2 Years 6 Months | Current |
| Rangnath Dnyaneshwar Gaikwad | Additional Director | 12 Nov 2024 | 1 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Primeval Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primeval Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Primeval Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Primeval Pharma Private Limited has 6 board changes on record since 2024: 2 appointments and 4 cessations. The latest: Rangnath Dnyaneshwar Gaikwad was appointed as Additional Director on 12 Nov 2024.
AGM
Primeval Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Primeval Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Rangnath Dnyaneshwar Gaikwad was appointed as Additional Director.
Ceased
Shivshankar Kondabarao Vyavhare ceased to be Director.
Ceased
Shrikant Madhavrao Kshirsagar ceased to be Additional Director.
Appointed
Shrikant Madhavrao Kshirsagar was appointed as Director.
Ceased
Tushar Shivaji Mulange ceased to be Director.
Ceased
Ravi Ramesh Shinde ceased to be Director.
Incorporation
08 Mar 2022
Primeval Pharma Private Limited was registered on 08 Mar 2022 with Roc Nagpur & aged 4 years 7 months as per MCA records.
Frequently asked questions
Primeval Pharma is an active private limited company based in Nanded, Maharashtra, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 08 March 2022 (4+ years old) and is registered under CIN U24299MH2022PTC378118.
Primeval Pharma has 2 current directors:
- Shrikant Madhavrao Kshirsagar - Director
- Rangnath Dnyaneshwar Gaikwad - Additional Director
The latest financial statements of Primeval Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Primeval Pharma is U24299MH2022PTC378118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primeval Pharma was incorporated on 08 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Nagpur.
Rangnath Dnyaneshwar Gaikwad was appointed as Additional Director on 12 Nov 2024. Shivshankar Kondabarao Vyavhare ceased to be Director on 12 Nov 2024. Shrikant Madhavrao Kshirsagar ceased to be Additional Director on 29 Sep 2024. Primeval Pharma has 6 board changes on record in total.
Yes, Primeval Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-21-0021173).
The registered office of Primeval Pharma is at Plot No.16 New Mondha Market Nanded Waghala M Corp, Maharashtra, India – 431603.
Primeval Pharma operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Primeval Pharma can be reached at its registered office: Plot No.16 New Mondha Market Nanded Waghala M Corp, Maharashtra, India – 431603.